We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunofluorescence Assay Developed for Hantaviruses

By LabMedica International staff writers
Posted on 15 Apr 2013
Simultaneous tests were developed for clinically important Old and New World hantaviruses using multiparametric indirect immunofluorescence assays (IFAs) based on biochip mosaics. More...


To detect serum antibodies each of the mosaic substrates consisted of cells infected with one of the virus types Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Saaremaa (SAAV), Dobrava (DOBV), Sin Nombre (SNV) or Andes (ANDV).

Scientists from the Euroimmun Medizinische Labordiagnostika AG, ( Luebeck, Germany) in collaboration with others, analyzed 184 laboratory-confirmed Hantavirus-positive sera collected at six diagnostic centers from patients actively or previously infected with different Hantavirus serotypes. The control panel comprised 89 sera from healthy blood donors. The Euroimmun’s Hantavirus Mosaic 1 and 3 were used for the multiparametric IFA-based detection of Hantavirus-specific immunoglobulin G (IgG) and IgM.

The overall qualitative performance of multiparametric IFAs in detecting anti-Hantavirus antibodies was analyzed by considering those samples as seropositive that showed specific reactivity with a cut-off 1:100, against at least one of the different Hantavirus serotypes contained in the biochip mosaics. In the multiparametric IFA applied in the study, 99% of the patient sera were IgG positive and 71% were IgM positive. Overall IFA sensitivity for combined IgG and IgM analysis amounted to 100% for all serotypes, except for SNV, which was 96%. Of the 89 control sera, 2% showed IgG reactivity against the HTNV substrate, but not against any other Hantavirus.

The authors concluded that analysis of Hantavirus-specific IgG and IgM by indirect immunofluorescence on substrate mosaics consisting of cells infected with different hantaviruses is a globally applicable. The method is a reliable diagnostic tool for screening of patients suspected of having Hantavirus infection, and can be useful for serotyping in areas where hantaviruses of different serogroups are endemic. The multiparametric IFA enables highly sensitive and specific serological diagnosis of Hantavirus infections and can be used to differentiate PUUV and ANDV infection from infections with Murinae-borne hantaviruses such as DOBV and SEOV. The study was published on April 4, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Euroimmun Medizinische Labordiagnostika AG



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.